Close Menu
Home › Alere Reports 2 Percent Dip in Q2 Revenues Despite Lift in Infectious Disease Sales

Alere Reports 2 Percent Dip in Q2 Revenues Despite Lift in Infectious Disease Sales

Sep 06, 2016
|
staff reporter

NEW YORK (GenomeWeb) – Alere today filed its financial results for the second quarter of 2016, reporting a 2 percent decrease in revenues year over year.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Dec
02
Featured Webinar

Comprehensive Profiling of Myeloid Malignancies with Reliable Detection of   FLT3  and  CEBPA

Sponsored by
Sophia Genetics

This webinar will discuss how Moffitt Cancer Center has implemented a new capture-based application to accurately assess myeloid malignancies by detecting complex variants in challenging genes in a single experiment.  

What's Popular?

In Molecular Diagnostics

  1. Qiagen Upgraded to Overweight by JP Morgan; Stock Surges on Thermo Fisher Buyout Speculation

  2. Exact Sciences Sues Johns Hopkins University for 'Improperly' Demanding Royalties

  3. FDA Clears NantHealth Tumor-Normal Whole-Exome Test

  4. Inflammatix Inks BARDA Contract for up to $72M

  5. AMP Attendees Reflect on Uptake of Tumor Mutational Burden Amid Validation, Utility Questions

    Premium

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.